Publications by authors named "Chureen Carter"

Claim this Profile
H
Healthcare resource utilization following ECG sensor patch screening for atrial fibrillation.
Jill Waalen, Alison M Edwards, Anirudh Sanyal, Robert A Zambon, Lauren Ariniello, Chureen Carter

Heart Rhythm O2· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital recruitment and enrollment in a remote nationwide trial of screening for undiagnosed atrial fibrillation: Lessons from the randomized, controlled mSToPS trial.
Katie Baca-Motes, Alison M Edwards, Jill Waalen, Shawn Edmonds, Rajesh R Mehta, Chureen T Carter

Contemp Clin Trials Commun· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial.
Steven R Steinhubl, Jill Waalen, Alison M Edwards, Lauren M Ariniello, Rajesh R Mehta, Chureen Carter

JAMA· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Preference for Dosing Frequency Based on Prior Biologic Experience.
Mingliang Zhang, Chureen Carter, William H Olson, Michael P Johnson, Susan K Brennem

J Drugs Dermatol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient reported health outcomes and non-adherence in psoriasis patients receiving adalimumab or ustekinumab for moderate to severe plaque psoriasis.
Amir Goren, Chureen Carter, Seina Lee

J Dermatolog Treat· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis.
David Pariser, Brad Schenkel, Chureen Carter, Kamyar Farahi, T Michelle Brown

J Dermatolog Treat· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trial.
Steven R Steinhubl, Rajesh R Mehta, Gail S Ebner, Marissa M Ballesteros, Jill Waalen, Chureen T Carter

Am Heart J· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis.
Mingliang Zhang, Susan K Brenneman, Chureen T Carter, Breanna L Essoi, Kamyar Farahi

Patient Prefer Adherence· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab dosing, persistence, and discontinuation patterns in patients with moderate-to-severe psoriasis.
Zhun Cao, Chureen Carter, Kathleen L Wilson, Brad Schenkel

J Dermatolog Treat· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative multidatabase analysis of dosing patterns and infusion intervals for the first 12 infliximab infusions in patients with rheumatoid arthritis.
Susan C Bolge, Chureen T Carter, Cynthia S Mueller, Robert A Bailey, Michael P Ingham

Clin Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a continuous measure of adherence with infliximab maintenance treatment on inpatient outcomes in Crohn's disease.
Chureen T Carter, Heidi C Waters, Daniel B Smith

Patient Prefer Adherence· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients.
Chureen T Carter, Arun K Changolkar, R Scott McKenzie

J Med Econ· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of infliximab adherence on Crohn's disease-related healthcare utilization and inpatient costs.
Chureen T Carter, Heidi C Waters, Daniel B Smith

Adv Ther· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of persistence with infliximab on hospitalizations in ulcerative colitis.
Chureen T Carter, Henry Leher, Paula Smith, Daniel B Smith, Heidi C Waters

Am J Manag Care· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and perceptions of treatment attributes, satisfaction and effectiveness among patients with psoriasis.
Marco daCosta DiBonaventura, Samuel Wagner, Heidi Waters, Chureen Carter

J Drugs Dermatol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health plan retention and pharmacy costs of newly diagnosed patients with chronic kidney disease in a managed care population.
Maureen Kubacki, Chureen Carter, Alan D L Herrera, Jim Wang, Janice M Lopez

Am Health Drug Benefits· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study.
Marya D Zilberberg, Chureen Carter, Patrick Lefebvre, Monika Raut, Francis Vekeman

Crit Care· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of illness among commercially insured patients with Alzheimer's disease.
Amie T Joyce, Yang Zhao, Lee Bowman, Jennifer A Flynn, Chureen T Carter

Alzheimers Dement· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspective.
Peggy S McKinnon, Chureen T Carter, Prafulla G Girase, Larry Z Liu, Yehuda Carmeli

Manag Care Interface· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of initial ziprasidone dose on length of therapy in schizophrenia.
Amie T Joyce, David J Harrison, Antony D Loebel, Chureen T Carter, Daniel A Ollendorf

Schizophr Res· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of constipation in patients prescribed fentanyl transdermal system or oxycodone hydrochloride controlled-release in a California Medicaid population.
Stacey J Ackerman, Tyler Knight, Jeff Schein, Chureen Carter, Peter Staats

Consult Pharm· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How does quality enter into health care purchasing decisions?
Neil I Goldfarb, Vittorio Maio, Chureen T Carter, Laura Pizzi, David B Nash

Issue Brief (Commonw Fund)· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis